SCHEMBL30751514

SCHEMBL30751514

CCOC(=O)c1cnc(N2CCCC2)nc1Nc1ccc(C2CC2)nc1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAPT P10636 6/20 0.53
▸ POLB P06746 1/20 0.53
▸ NPSR1 Q6W5P4 8/20 0.51
▸ SMN1; SMN2 Q16637 3/20 0.51
▸ MEN1 O00255 2/20 0.51
▸ KMT2A Q03164 2/20 0.51
▸ XBP1 P17861 2/20 0.50
▸ RAB9A P51151 2/20 0.50
▸ ALDH1A1 P00352 4/20 0.48
▸ HTT P42858 2/20 0.48
▸ MAPK1 P28482 2/20 0.48
▸ LMNA P02545 2/20 0.48
▸ SYK P43405 2/20 0.48
▸ L3MBTL1 Q9Y468 1/20 0.48
▸ ALOX15 P16050 4/20 0.47
▸ NR2F2 P24468 2/20 0.47
▸ KDM4E B2RXH2 2/20 0.47
▸ NPC1 O15118 2/20 0.47
▸ S1PR2 O95136 1/20 0.47
▸ PPP1CA P62136 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30751577 0.85 CAMK1D (0.48) STK17APDE4BCAMK1D
SCHEMBL31673014 0.84 STK17A (0.46) MAPTSTK17APDE4BCAMK1D
SCHEMBL31673049 0.84 CAMK1D (0.59) PDE4BCAMK1D
Hydrochloric Acid SCHEMBL31673031 0.83 STK17A (0.46) MAPTSTK17APDE4BCAMK1D
SCHEMBL31673012 0.83 CAMK1D (0.46) MAPTSTK17APDE4BCAMK1D
Lithium Ion SCHEMBL31673020 0.83 CAMK1D (0.46) STK17APDE4BCAMK1D
SCHEMBL30751508 0.83 PTPN11 (0.55) PDE4BCAMK1D
SCHEMBL30751533 0.82 PTPN11 (0.54) MAPTPOLBNPSR1SMN1; SMN2MEN1
SCHEMBL14590422 0.78 MAPT (0.63) MAPTPOLBNPSR1SMN1; SMN2MEN1
SCHEMBL30751519 0.77 SYK (0.56) SYKPDE4BCAMK1D

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250257051-A1 SUBSTITUTED PYRIMIDINE COMPOUNDS AS TYK2 INHIBITORS 1910 GENETICS INC (US) 2025-08-14 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250257051-A1 SUBSTITUTED PYRIMIDINE COMPOUNDS AS TYK2 INHIBITORS TYK2, PDXK, JAK1 MAPT 943/4885POLB 826/4885NPSR1 3138/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback